Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

MY-1B

(Synonyms: MY1B) Copy Product Info
😃Good

Synonyms: MY1B

Catalog No. T85335 Copy Product Info
Purity: 99.81%
😃Good
MY-1B is a covalent inhibitor and an inhibitor of RNA methyltransferase NSUN2 (IC50 = 1.3 μM), featuring stereoselectivity, covalent binding to C271 of NSUN2, and the ability to target PSME1, disrupt proteasome regulatory complexes, and downregulate presentation of specific MHC-I subtypes.
MY-1B
Cas No. 2929308-79-0
Pack SizePriceUSA StockGlobal StockQuantity
1 mg$129In StockIn Stock
5 mg$321In StockIn Stock
10 mg$511In StockIn Stock
25 mg$1,020In StockIn Stock
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.81%
ee:100%
Appearance:Solid
Color:White to Yellow
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
MY-1B is a covalent inhibitor and an inhibitor of RNA methyltransferase NSUN2 (IC50 = 1.3 μM), featuring stereoselectivity, covalent binding to C271 of NSUN2, and the ability to target PSME1, disrupt proteasome regulatory complexes, and downregulate presentation of specific MHC-I subtypes.
Targets & IC50
NSUN2 methyltransferase:67 ± 15 M (Kinact/Ki), NSUN2:1.3 μM, NSUN2:2.4 µM (RNA methylation assays)
In vitro
Methods: The inhibitory effect of MY-1B (2.5–20 µM, 0–2000 seconds) on NSUN2 methyltransferase activity was determined by enzyme kinetic assays.
Results: MY-1B inhibited NSUN2 activity with a Kinact/Ki value of 67 ± 15 M⁻¹.[1]
Methods: In HEK293T cells, MY-1B (6.25–100 μM) was used to treat for 2 hours to assess binding to C1113 of DCAF1 protein.
Results: MY-1B served as a stereo- and site-selective covalent ligand for C1113 of DCAF1.[2]
Methods: In human prostate cancer cell lines, MY-1B (5 or 20 µM) was used to treat for 3 hours to assess binding to C271 of NSUN2 protein.
Results: MY-1B bound to C271 of NSUN2 with stereoselectivity and site specificity.[3]
SynonymsMY1B
Chemical Properties
Molecular Weight436.3
FormulaC22H18BrN3O2
Cas No.2929308-79-0
SmilesC(NC=1C2=C(C=CC1)C=CC=N2)(=O)[C@H]3[C@H](CN3C(C=C)=O)C4=CC=C(Br)C=C4
Relative Density.no data available
Storage & Solubility Information
StorageKeep away from moisture Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 80 mg/mL (183.36 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 3.3 mg/mL (7.56 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.2920 mL11.4600 mL22.9200 mL114.6000 mL
5 mM0.4584 mL2.2920 mL4.5840 mL22.9200 mL
10 mM0.2292 mL1.1460 mL2.2920 mL11.4600 mL
20 mM0.1146 mL0.5730 mL1.1460 mL5.7300 mL
50 mM0.0458 mL0.2292 mL0.4584 mL2.2920 mL
100 mM0.0229 mL0.1146 mL0.2292 mL1.1460 mL
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 µL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 µL Tween 80 and mix well until fully clarified.

3) Add 450 µL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
µL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: MY-1B chemical structure | MY-1B in vitro | MY-1B formula | MY-1B molecular weight